Sintx Technologies, Inc. (0A8S.L)
LSE · USD
$1.73 (+8.67%) as of
Key statistics
- EPS (TTM)
- -0.3940
- 52-week range
- 0.1191 – 2.4700
- Beta
- 0.59
- Revenue (TTM)
- 1.33M
- Profit margin
- 0.00%
- Volume
- 20.00
About Sintx Technologies, Inc.
Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). It also provides insulators for Tier 1 aerospace suppliers; SiNAPTIC® Foot & Ankle Osteotomy Wedge System for reconstructive surgery; OEM manufacturing of spinal implants; and SiNERGY technology platform for bio composite and 3D printing applications. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
- Headquarters
- Salt Lake City, UT, United States
- Employees
- 32
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.